| Market Cap | 62.59B | P/E | 30.33 | EPS this Y | - | Ern Qtrly Grth | 3.90% |
| Income | 1.78B | Forward P/E | 30.05 | EPS next Y | - | 50D Avg Chg | 2.00% |
| Sales | 9.16B | PEG | - | EPS past 5Y | 4.99% | 200D Avg Chg | 9.00% |
| Dividend | 2.00% | Price/Book | 76.35 | EPS next 5Y | 7.10% | 52W High Chg | -4.00% |
| Recommedations | 1.50 | Quick Ratio | 0.40 | Shares Outstanding | 1.87B | 52W Low Chg | 41.00% |
| Insider Own | - | ROA | 10.71% | Shares Float | 1.86B | Beta | 0.46 |
| Inst Own | 3.74% | ROE | 49.72% | Shares Shorted/Prior | 2.86M/2.75M | Price | 33.06 |
| Gross Margin | 64.90% | Profit Margin | 19.44% | Avg. Volume | 805,991 | Target Price | 50.99 |
| Oper. Margin | 29.04% | Earnings Date | - | Volume | 776,220 | Change | -0.63% |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.